Core Laboratories Inc. (NYSE:CLB) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp trimmed its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 450,013 shares of the oil and gas company's stock after selling 28,026 shares during the quarter. Bank of New York Mellon Corp owned 0.96% of Core Laboratories worth $7,790,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp raised its stake in Core Laboratories by 2.9% in the third quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company's stock worth $36,597,000 after buying an additional 56,187 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Core Laboratories by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company's stock worth $19,521,000 after acquiring an additional 7,721 shares in the last quarter. Boston Trust Walden Corp lifted its stake in shares of Core Laboratories by 2.7% during the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company's stock worth $10,686,000 after purchasing an additional 16,503 shares during the last quarter. Barclays PLC boosted its position in Core Laboratories by 288.2% during the third quarter. Barclays PLC now owns 83,570 shares of the oil and gas company's stock valued at $1,549,000 after purchasing an additional 62,042 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in Core Laboratories by 3.1% in the fourth quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company's stock valued at $3,966,000 after purchasing an additional 6,827 shares during the last quarter. Institutional investors own 97.81% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Separately, Citigroup raised shares of Core Laboratories from a "sell" rating to a "neutral" rating and increased their price target for the company from $15.00 to $16.00 in a research report on Wednesday, March 12th. One analyst has rated the stock with a sell rating and four have given a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $17.50.

Core Laboratories Stock Up 1.9 %

CLB stock traded up $0.29 on Wednesday, hitting $15.48. 104,697 shares of the company's stock were exchanged, compared to its average volume of 335,903. The firm has a 50 day moving average price of $16.96 and a two-hundred day moving average price of $18.25. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. Core Laboratories Inc. has a 12-month low of $12.95 and a 12-month high of $25.13. The stock has a market cap of $725.07 million, a P/E ratio of 23.45, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. As a group, equities research analysts expect that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories's dividend payout ratio (DPR) is presently 6.06%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.